CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity
CDK5 is known to drive glioblastoma tumorigenicity but the downstream molecular mechanism is unknown. Here, the authors show that CDK5 activates STAT3 signalling via the nuclear import of TRIM59, which leads to the degradation of the tumour suppressor macroH2A1.
Saved in:
Main Authors: | Youzhou Sang, Yanxin Li, Yingwen Zhang, Angel A. Alvarez, Bo Yu, Weiwei Zhang, Bo Hu, Shi-Yuan Cheng, Haizhong Feng |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/c4a497b4b1e04bd3908f0826fd4ebcfd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LSH mediates gene repression through macroH2A deposition
by: Kai Ni, et al.
Published: (2020) -
CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP+-induced Parkinson’s disease model
by: Feng-Juan Jiao, et al.
Published: (2017) -
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
by: Deguan Lv, et al.
Published: (2017) -
Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
by: Francesca Rappa, et al.
Published: (2013) -
TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
by: Zheng Jin, et al.
Published: (2021)